Tursi, Antonio <br/><br/>
Budesonide MMX Is Effective in Patients Having Persistent Symptoms and Raised Fecal Calprotectin Following Treatments for Diverticular Disease.  [electronic resource] 

 -  Journal of gastrointestinal and liver diseases : JGLD  Dec 2019 
 - 45-48 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1842-1121 
<br/><br/><label>Standard No.: </label>10.15403/jgld-559  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Budesonide--administration & dosage<br/>Colonic Diseases--drug therapy<br/>Diverticular Diseases--drug therapy<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Feces--chemistry<br/>Female<br/>Follow-Up Studies<br/>Gastrointestinal Agents--administration & dosage<br/>Glucocorticoids--administration & dosage<br/>Humans<br/>Leukocyte L1 Antigen Complex--metabolism<br/>Male<br/>Mesalamine--therapeutic use<br/>Middle Aged<br/>Severity of Illness Index<br/>Treatment Outcome